Allurion to Participate in the Jefferies Healthcare Conference

MicrosoftTeams-image (207).png
11 (1).jpg

Allurion to Participate in the Jefferies Healthcare Conference

NATICK, Mass. -- May 30, 2023 – Allurion, a company dedicated to ending obesity, today announced that it will be participating in the Jefferies Healthcare Conference taking place at the Marriott Marquis, New York, NY on June 7-9, 2023. Shantanu Gaur, Allurion’s Chief Executive Officer, and Chris Geberth, Chief Financial Officer, will present on Friday, June 9, 2023 at 9:30 A.M. Eastern Time, and will be available for investor 1x1 meetings.

A webcast of the event will be available on the Allurion website.

About Allurion

Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional.

The Allurion Program combines a 4-month swallowable gastric balloon with a 6-month behavior change and weight-loss program that is supported by a suite of digital tools that facilitate monitoring, coaching and telehealth. For more information about Allurion and the Allurion Virtual Care Suite, please visit

Media Contact  

Cedric Damour 

PR Manager  

+33 7 84 21 02 20

Investor Contact

Mike Cavanaugh, Investor Relations
ICR Westwicke
(617) 877-9641